81 related articles for article (PubMed ID: 16105969)
1. Immunohistochemical localization of CCK1 cholecystokinin receptors in normal and neoplastic human tissues.
Schulz S; Röcken C; Mawrin C; Schulz S
J Clin Endocrinol Metab; 2005 Nov; 90(11):6149-55. PubMed ID: 16105969
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical identification of low-affinity NTS2 neurotensin receptors in parietal cells of human gastric mucosa.
Schulz S; Röcken C; Ebert MP; Schulz S
J Endocrinol; 2006 Oct; 191(1):121-8. PubMed ID: 17065395
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of full-length NK1 tachykinin receptors in human tumors.
Schulz S; Stumm R; Röcken C; Mawrin C; Schulz S
J Histochem Cytochem; 2006 Sep; 54(9):1015-20. PubMed ID: 16651388
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies.
Schulz S; Röcken C; Schulz S
Virchows Arch; 2006 Oct; 449(4):421-7. PubMed ID: 16967266
[TBL] [Abstract][Full Text] [Related]
6. Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine.
Sternini C; Wong H; Pham T; De Giorgio R; Miller LJ; Kuntz SM; Reeve JR; Walsh JH; Raybould HE
Gastroenterology; 1999 Nov; 117(5):1136-46. PubMed ID: 10535877
[TBL] [Abstract][Full Text] [Related]
7. Reevaluation of sst₁ somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7.
Lupp A; Nagel F; Schulz S
Regul Pept; 2013 May; 183():1-6. PubMed ID: 23466804
[TBL] [Abstract][Full Text] [Related]
8. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue.
Reubi JC; Waser B; Gugger M; Friess H; Kleeff J; Kayed H; Büchler MW; Laissue JA
Gastroenterology; 2003 Jul; 125(1):98-106. PubMed ID: 12851875
[TBL] [Abstract][Full Text] [Related]
9. Cellular and subcellular localization of cholecystokinin (CCK)-1 receptors in the pancreas, gallbladder, and stomach of mice.
Konno K; Takahashi-Iwanaga H; Uchigashima M; Miyasaka K; Funakoshi A; Watanabe M; Iwanaga T
Histochem Cell Biol; 2015 Mar; 143(3):301-12. PubMed ID: 25249350
[TBL] [Abstract][Full Text] [Related]
10. Reassessment of sst3 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-5.
Lupp A; Nagel F; Doll C; Röcken C; Evert M; Mawrin C; Saeger W; Schulz S
Neuroendocrinology; 2012; 96(4):301-10. PubMed ID: 22414742
[TBL] [Abstract][Full Text] [Related]
11. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.
Langmesser S; Cerezo-Guisado MI; Lorenzo MJ; Garcia-Marin LJ; Bragado MJ
J Cell Biochem; 2007 Mar; 100(4):851-64. PubMed ID: 17226751
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning, expression and pharmacological characterization of the canine cholecystokinin 1 receptor.
Morton MF; Pyati J; Dai H; Li L; Moreno V; Shankley NP
Br J Pharmacol; 2005 Jun; 145(3):374-84. PubMed ID: 15765098
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues.
Lupp A; Klenk C; Röcken C; Evert M; Mawrin C; Schulz S
Eur J Endocrinol; 2010 May; 162(5):979-86. PubMed ID: 20156969
[TBL] [Abstract][Full Text] [Related]
14. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody.
Schulz S; Röcken C; Schulz S
Eur J Cancer; 2006 Sep; 42(14):2390-6. PubMed ID: 16904887
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical examination of cholecystokinin and gastrin receptors (CCK-2/gastrin-R) expression in normal and exocrine cancerous human pancreatic tissues.
Sellam F; Harir N; Khaled MB; Mrabent NM; Belkralladi H; Tou A; Diaf M; Salah R; Moulessehoul S
Pancreatology; 2015; 15(6):661-6. PubMed ID: 26520651
[TBL] [Abstract][Full Text] [Related]
18. Sequence variation outside the "active" region of dog and rabbit cholecystokinin-58 results in bioactivity differences.
Reeve JR; Liddle RA; Shively JE; Lee TD; Keire DA; Chew P; Vigna SR
Pancreas; 2006 Apr; 32(3):306-13. PubMed ID: 16628087
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin (CCK) stimulates aldosterone secretion from human adrenocortical cells via CCK2 receptors coupled to the adenylate cyclase/protein kinase A signaling cascade.
Mazzocchi G; Malendowicz LK; Aragona F; Spinazzi R; Nussdorfer GG
J Clin Endocrinol Metab; 2004 Mar; 89(3):1277-84. PubMed ID: 15001623
[TBL] [Abstract][Full Text] [Related]
20. CCK1 antagonists: are they ready for clinical use?
Peter SA; D'Amato M; Beglinger C
Dig Dis; 2006; 24(1-2):70-82. PubMed ID: 16699265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
